Log in with your email address username.

×

[Comment] Olaratumab in soft-tissue sarcomas

More than 40 years after Benjamin and colleagues1 reported the benefit of doxorubicin in metastatic soft-tissue sarcomas, doxorubicin either as monotherapy or in combination with ifosfamide is still the standard first-line treatment in most soft-tissue sarcomas.2

email